"10.1371_journal.pone.0101419","plos one","2014-06-27T00:00:00Z","Grant A Hill-Cawthorne; Lyndsey O Hudson; Moataz Fouad Abd El Ghany; Olaf Piepenburg; Mridul Nair; Andrew Dodgson; Matthew S Forrest; Taane G Clark; Arnab Pain","Pathogen Genomics Laboratory, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia; Marie Bashir Institute for Infectious Diseases and Biosecurity and Sydney School of Public Health, University of Sydney, Sydney, Australia; Department of Infectious Disease Epidemiology, Imperial College London, London, United Kingdom; TwistDx Ltd., Babraham, United Kingdom; Microbiology Dept, Central Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom","Conceived and designed the experiments: GAH-C OP MSF LOH AP. Performed the experiments: GAH-C LOH MFAEG MN AD MSF. Analyzed the data: GAH-C LOH MSF. Contributed reagents/materials/analysis tools: OP MSF AD TGC AP. Contributed to the writing of the manuscript: GAH-C LOH MSF AD OP MFAEG MN TGC AP. Collected the nasal and groin swabs and carried out routine MRSA screening: AD. Developed the recombinase polymerase amplification assay, designed the primer sequences and isolated DNA from the MRSA isolates: MSF OP. Tested the RPA assay and performed spa typing and MLST: LOH. Purified the DNA and prepared whole-genome sequencing libraries: MFAEG MN. Assembled the genomes and performed the bioinformatics analysis: GAH-C. Wrote the first draft of the manuscript: GAH-C LOH MSF. Designed the original project to design and test an RPA assay for MRSA: MSF OP LOH AD. Designed the WGS project: GAH-C TGC AP MSF. Contributed to editing the manuscript: GAH-C LOH MFAEG OP MN AD MSF TGC AP.","Olaf Piepenburg and Matthew S. Forrest are employed by TwistDx, and have a stake in the success of its technology. TwistDx is one of the funders of this study and is a UK based company, with a commercial interest in the use of the RPA technology for the detection of hospital-acquired pathogens. TwistDx Ltd, is the developer and manufacturer of RPA technology and is part of the of the Alere group of companies. Lyndsey O. Hudson was the recipient of a BBSRC CASE-funded PhD studentship from TwistDx. This work was also supported by Smart Solutions for HCAI. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","06","Grant A Hill-Cawthorne","GAHC",9,TRUE,5,6,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
